PCA
LLY icon

Purkiss Capital Advisors’s Eli Lilly LLY Stock Holding History

Purkiss Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
939
+65
+7% +$66.4K 0.43% 55
2026
Q1 		$804K Buy
874
+21
+2% +$21.3K 0.35% 69
2025
Q4 		$916K Sell
853
-49
-5% -$46.9K 0.43% 51
2025
Q3 		$688K Sell
902
-135
-13% -$100K 0.33% 64
2025
Q2 		$808K Buy
1,037
+462
+80% +$359K 0.45% 49
2025
Q1 		$475K Sell
575
-11
-2% -$9.15K 0.36% 53
2024
Q4 		$452K Buy
+586
New +$485K 0.39% 49

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Purkiss Capital Advisors's LLY Position: Q2 2026 in Review

Purkiss Capital Advisors increased its Eli Lilly (LLY) stake by 7.4% in Q2 2026, buying an estimated $66.4K and bringing the position to 939 shares worth $1.13M. The position accounts for 0.43% of the portfolio, ranked #55.

Purkiss Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Purkiss Capital Advisors held 939 shares of Eli Lilly worth $1.13M as of Q2 2026.
  • Purkiss Capital Advisors bought 65 Eli Lilly shares in Q2 2026, an estimated $66.4K.
  • Eli Lilly made up 0.43% of Purkiss Capital Advisors's portfolio in Q2 2026, its #55 holding.
  • Purkiss Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.